피질하 혈관성치매의 진단, 치료 및 예방:1례 보고와 함께
Diagnosis, Treatment and Prevention of Subcortical Vascular Dementia with a Case Report
1
조회
0
다운로드
7
인용
0
참고문헌
키워드
초록
Vascular dementia(VaD) is currently considered to be the second most common type of dementia. VaD is not a single diagnostic entity, but a heterogeneous syndrome which encompasses several clinico- pathological forms of dementia resulting from cerebrovascular diseases. A common form of VaD is subcortical VaD which is characterized by lacunar infarcts and deep white matter changes, leading to a progressive decline in memory and cognitive function. The neuropsychological and cognitive profiles of subcortical VaD have been reported relatively homogeneous. At present, subcortical vascular dementia is regarded as the most important subtype of VaD with getting the attention of vascular dementia. The aims of this study are to discuss the concept of subcortical VaD and its importance focusing on diagnosis, prevention and treatment with a case report.
Abstract
Vascular dementia(VaD) is currently considered to be the second most common type of dementia. VaD is not a single diagnostic entity, but a heterogeneous syndrome which encompasses several clinico- pathological forms of dementia resulting from cerebrovascular diseases. A common form of VaD is subcortical VaD which is characterized by lacunar infarcts and deep white matter changes, leading to a progressive decline in memory and cognitive function. The neuropsychological and cognitive profiles of subcortical VaD have been reported relatively homogeneous. At present, subcortical vascular dementia is regarded as the most important subtype of VaD with getting the attention of vascular dementia. The aims of this study are to discuss the concept of subcortical VaD and its importance focusing on diagnosis, prevention and treatment with a case report.
참고문헌 (24)
- 조맹제, "치매 노인 유병률 조사", 보건복지가족부, ~ (2008)
- Geldmacher DS, "Evaluation of dementia", N Engl J Med, 335(5), pp.330~336 (1996)
- Roman GC, "Vascular dementia : diagnostic criteria for research studies : report of the NINDS-AIREN international workshop", Neurology, 43, pp.250~252 (1993)
- 대한치매학회, "치매 임상적 접근", pp.347~447 (2006), 아카데미아
- de la Torr JC, "Vascular risk factor detection and control may prevent Alzheimer’s diseas", Ageing Research Review, 9, pp.218~225 (2010)
- Chiu HC, "Dementia due to subcortical ischemic vascular disease", Clin Cornerstone, 3(4), pp.40~51 (2001)
- Chiu HC, "Vascular dementia, a new beginning : shifting focus from clinical phenotype to ischemic brain injury", Neurol Clin, 18, pp.951~978 (2000)
- Roman GC, "Subcortical ischaemic vascular dementia", Lancet Neurol, 1, pp.426~436 (2002)
- 안탁원, "뇌혈관성치매에 대한 동서의학적 고찰", 한국한의학연구원논문집, 2(1), pp.40~70 (1996)
- 현경철, "Vascular Dementia에 관한 한의학적 임상연구", 동의신경정신과학회지, 10(1), pp.147~157 (1999)
- Roman GC, "Vascular dementia : distinguishing characteristics, treatment and prevention", J Am Geriatr Soc, 51, pp.296~304 (2003)
- Erkinjuntti T, "Research criteria for subcortical vascular dementia in clinical trials", J Neural Transm Suppl, 59, pp.23~30 (2000)
- Bowler JV, "Vascular cognitive impairment", J Neurol Neurosurg Psychiatry, 76(Suppl V), pp.v35~v44 (2005)
- 이재홍, "혈관성치매의 치료", 대한신경과학회지, 21(5), pp.1~454 (2003), 대한신경과학회
- Orgogozo JM, "Efficacy and safety of memantine in patients with mild to moderate vascular dementia : a randomized, placebo-controlled trial (MMM 300)", Stroke, 33, pp.1834~1839 (2002)
- Rogers SL, "Long-term efficacy and safety of donepezil in the treatment of Alzheimer’s disease : final analysisof a US multicentre openlabel study", Eur. Neuropsychopharmacol, 10, pp.195~203 (2000)
- Pratt RD, "Results of clinical studies with donepezil in vascular dementia", Am J Geriatr Psychiatry, 10(Suppl. 1), pp.88~89 (2002)
- Black S, "Efficacy and tolerability of donepezil in vascular dementia : Positive results of a 24- week, multicenter, international, randomized, placebo-controlled clinical trial", Stroke, 34, pp.2323~2330 (2003)
- Moretti R, "Rivastigmine in subcortical vascular dementia : An open 22-month study", J Neurol Sci, 203, pp.141~146 (2002)
- Santos MD, "The nicotinic allosteric potentiating ligand galantamine facilitates synaptic transmission in the mammalian central nervous system", Mol Pharmacol, 61, pp.1222~1234 (2002)
- Erkinjuntti T, "Efficacy of galantamine in probable vascular dementia and Alzheimer’s disease combined with cerebrovascular disease : A randomised trial", Lancet, 359, pp.1283~1290 (2002)
- Forette F, "Prevention of dementia in randomised double-blind placebocontrolled Systolic Hypertension in Europe (Syst-Eur) trial", Lancet, 352(9137), pp.1347~1351 (1998)
- Kang YW, "A validity study on the Korean Mini-Mental State Examination(K-MMSE) in dementia patients", J Korean Neurol Assoc, 15, pp.300~307 (1997)
- Kang Y, "Samsung Neuropsychological Screening Battery. In : Current research in dementia", pp.99~107 (1998), The Korean Dementia Association